CVT’s new headquarters billed as centre of excellence for health products
Cold-fX gets a "Home of Our Own!"
 
CV Technologies Is Set for Growth, Says CEO
CV Technologies' recent financial and operational performance sets the stage for successful long-term growth through product line and geographic diversification, said President, CEO and Chief Scientific Officer Dr. Jacqueline Shan...
 
COLD-fX(R) Chosen Canada's # 1 Pharmacist Recommended Natural Cold Remedy for the Third Year in a Row.
Sixty-nine percent of Canadian pharmacists polled recommend COLD-fX as their first choice among natural cold remedies to their customers...
 
COLD-fX(R) Explores Children's Market
CV Technologies Releases Positive Safety Results of Pilot Clinical Trial as First Step
 
 
 

This website is not intended for residents of the United States.



 Toronto Stock Exchange - CVQ
Last Trade 0.590
  Change 0.115  
  Volume 133,234  
  Day High 0.590  
  Day Low 0.480  
  Ask 0.590  
  Ask Size 28  
  Bid 0.580  
  Bid Size 10  

Contact UsLegal Terms & ConditionsPrivacy PolicySite Map
   

* Trademarks owned by CV Technologies Inc.
This website is not intended for residents of the United States.